• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MHCII 呈递的新抗原是否会引发 1 型糖尿病和其他自身免疫性疾病?

Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?

机构信息

Howard Hughes Medical Institute and Integrated Department of Immunology, National Jewish Health, University of Colorado Denver, School of Medicine, Denver, CO 80206, USA.

出版信息

Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a007765. doi: 10.1101/cshperspect.a007765.

DOI:10.1101/cshperspect.a007765
PMID:22951444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3426820/
Abstract

The strong association between particular MHCII alleles and type 1 diabetes is not fully understood. Two ideas that have been considered for many years are that autoimmunity is driven by (1) low-affinity CD4(+) T cells that escape thymic negative selection and respond to certain autoantigen peptides that are particularly well presented by particular MHCII molecules, or (2) CD4(+) T cells responding to neoantigens that are absent in the thymus, but uniquely created in the target tissue in the periphery and presented by particular MHCII alleles. Here we discuss the recent structural data in favor of the second idea. We review studies suggesting that peptide antigens recognized by autoimmune T cells are uniquely proteolytically processed and/or posttranslationally modified in the target tissue, thus allowing these T cells to escape deletion in the thymus during T-cell development. We postulate that an encounter with these tissue-specific neoantigenic peptides presented by the particular susceptible MHCII alleles in the peripheral tissues when accompanied by the appropriate inflammatory milieu activates these T-cell escapees leading to the onset of autoimmune disease.

摘要

特定 MHCII 等位基因与 1 型糖尿病之间的强关联尚不完全清楚。多年来人们考虑了两个想法:自身免疫是由(1)低亲和力 CD4(+)T 细胞驱动的,这些细胞逃避了胸腺负选择,并对某些特别由特定 MHCII 分子呈递的自身抗原肽产生反应,或者(2)对胸腺中不存在但在外周靶组织中独特产生并由特定 MHCII 等位基因呈递的新抗原产生反应的 CD4(+)T 细胞。在这里,我们讨论了支持第二个想法的最新结构数据。我们回顾了一些研究,这些研究表明,自身免疫 T 细胞识别的肽抗原在靶组织中被独特地蛋白水解加工和/或翻译后修饰,从而使这些 T 细胞在 T 细胞发育过程中逃避胸腺中的删除。我们假设,在外周组织中遇到由特定易感 MHCII 等位基因呈递的这些组织特异性新抗原肽,并伴有适当的炎症环境,会激活这些 T 细胞逃避免疫,从而导致自身免疫疾病的发生。

相似文献

1
Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?MHCII 呈递的新抗原是否会引发 1 型糖尿病和其他自身免疫性疾病?
Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a007765. doi: 10.1101/cshperspect.a007765.
2
Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor.单个高致糖尿病 T 细胞受体识别多种混合胰岛素肽。
Front Immunol. 2021 Aug 30;12:737428. doi: 10.3389/fimmu.2021.737428. eCollection 2021.
3
Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.保护性MHC II类分子对致糖尿病CD4 + 胸腺细胞的自身抗原非依赖性清除
J Immunol. 1999 Apr 15;162(8):4627-36.
4
Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.在非肥胖型糖尿病(NOD)小鼠中,1 型糖尿病中胰岛素反应性 CD4+ T 细胞的特异性和检测。
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16729-34. doi: 10.1073/pnas.1113954108. Epub 2011 Sep 26.
5
Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.胸腺中胰岛抗原特异性T细胞的阳性选择及外周激活:通过I-A(g7) II类MHC β链突变体分离两个致糖尿病步骤
J Immunol. 1998 Nov 1;161(9):4489-92.
6
A new look at MHC and autoimmune disease.对主要组织相容性复合体与自身免疫性疾病的新认识。
Science. 1999 Apr 30;284(5415):749, 751. doi: 10.1126/science.284.5415.749.
7
Absence of nonhematopoietic MHC class II expression protects mice from experimental autoimmune myocarditis.非造血 MHC Ⅱ类表达缺失可保护小鼠免于实验性自身免疫性心肌炎。
Eur J Immunol. 2016 Mar;46(3):656-64. doi: 10.1002/eji.201545945. Epub 2015 Dec 22.
8
Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection.调节性T细胞的胸腺定向是一种TCR依赖性选择途径,可分离经历阳性或阴性选择的库。
Curr Top Microbiol Immunol. 2005;293:43-71. doi: 10.1007/3-540-27702-1_3.
9
Hidden in Plain View: Discovery of Chimeric Diabetogenic CD4 T Cell Neo-Epitopes.显性嵌合致糖尿病性 CD4 T 细胞新表位的发现。
Front Immunol. 2021 Apr 27;12:669986. doi: 10.3389/fimmu.2021.669986. eCollection 2021.
10
Thymic development of autoreactive T cells in NOD mice is regulated in an age-dependent manner.NOD 小鼠自身反应性 T 细胞的胸腺发育受年龄依赖性调节。
J Immunol. 2013 Dec 15;191(12):5858-66. doi: 10.4049/jimmunol.1302273. Epub 2013 Nov 6.

引用本文的文献

1
Neuromodulation influences T lymphocyte calcium signaling and alpha synuclein clearance: implications for Parkinson's disease.神经调节影响T淋巴细胞钙信号传导和α-突触核蛋白清除:对帕金森病的启示。
Front Cell Neurosci. 2025 Jul 18;19:1627305. doi: 10.3389/fncel.2025.1627305. eCollection 2025.
2
Immunotherapy for Type 1 Diabetes: Mechanistic Insights and Impact of Delivery Systems.1型糖尿病的免疫疗法:作用机制见解及递送系统的影响
Curr Pharm Des. 2025;31(12):925-933. doi: 10.2174/0113816128343081241030054303.
3
A mutagenesis study of autoantigen optimization for potential T1D vaccine design.自身抗原优化的诱变研究,用于潜在的 1 型糖尿病疫苗设计。
Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2214430120. doi: 10.1073/pnas.2214430120. Epub 2023 Apr 11.
4
A Novel Tolerogenic Antibody Targeting Disulfide-Modified Autoantigen Effectively Prevents Type 1 Diabetes in NOD Mice.一种新型免疫耐受抗体靶向二硫键修饰自身抗原可有效预防 NOD 小鼠 1 型糖尿病。
Front Immunol. 2022 Aug 11;13:877022. doi: 10.3389/fimmu.2022.877022. eCollection 2022.
5
Activation pathways that drive CD4 T cells to break tolerance in autoimmune diseases.驱动 CD4 T 细胞在自身免疫性疾病中打破耐受的激活途径。
Immunol Rev. 2022 May;307(1):161-190. doi: 10.1111/imr.13071. Epub 2022 Feb 10.
6
Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering.通过再生医学和组织工程恢复 1 型糖尿病中的正常胰岛质量和功能。
Lancet Diabetes Endocrinol. 2021 Oct;9(10):708-724. doi: 10.1016/S2213-8587(21)00170-4. Epub 2021 Sep 1.
7
Hidden in Plain View: Discovery of Chimeric Diabetogenic CD4 T Cell Neo-Epitopes.显性嵌合致糖尿病性 CD4 T 细胞新表位的发现。
Front Immunol. 2021 Apr 27;12:669986. doi: 10.3389/fimmu.2021.669986. eCollection 2021.
8
A Triple Threat? The Role of Diet, Nutrition, and the Microbiota in T1D Pathogenesis.三重威胁?饮食、营养和微生物群在1型糖尿病发病机制中的作用
Front Nutr. 2021 Apr 1;8:600756. doi: 10.3389/fnut.2021.600756. eCollection 2021.
9
Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation.趋化因子新抗原诱导的铍特异性 CD4+T 细胞持续炎症。
J Clin Invest. 2021 May 3;131(9). doi: 10.1172/JCI144864.
10
Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation.帕金森病的遗传和环境因素集中在免疫功能和炎症上。
Mov Disord. 2021 Jan;36(1):25-36. doi: 10.1002/mds.28411. Epub 2020 Dec 14.

本文引用的文献

1
Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.在非肥胖型糖尿病(NOD)小鼠中,1 型糖尿病中胰岛素反应性 CD4+ T 细胞的特异性和检测。
Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16729-34. doi: 10.1073/pnas.1113954108. Epub 2011 Sep 26.
2
Regulatory T cell lineage commitment in the thymus.胸腺中调节性 T 细胞谱系的决定。
Semin Immunol. 2011 Dec;23(6):401-9. doi: 10.1016/j.smim.2011.06.003. Epub 2011 Jul 6.
3
Making sense of regulatory T cell suppressive function.解析调节性 T 细胞的抑制功能。
Semin Immunol. 2011 Aug;23(4):282-92. doi: 10.1016/j.smim.2011.04.003. Epub 2011 May 17.
4
Control of central and peripheral tolerance by Aire.Aire 对中枢和外周耐受的控制。
Immunol Rev. 2011 May;241(1):89-103. doi: 10.1111/j.1600-065X.2011.01008.x.
5
Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice.前沿:血管抑肽-1 衍生肽 ChgA29-42 是 NOD 小鼠致糖尿病 BDC2.5 T 细胞的抗原表位。
J Immunol. 2011 Apr 1;186(7):3831-5. doi: 10.4049/jimmunol.1003617. Epub 2011 Feb 28.
6
Integration of genetic and immunological insights into a model of celiac disease pathogenesis.将遗传和免疫学见解整合到乳糜泻发病机制模型中。
Annu Rev Immunol. 2011;29:493-525. doi: 10.1146/annurev-immunol-040210-092915.
7
Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes.调节性 T 细胞分化与自身反应性胸腺细胞的克隆删除。
Immunol Cell Biol. 2011 Jan;89(1):45-53. doi: 10.1038/icb.2010.123. Epub 2010 Nov 2.
8
Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.致糖尿病的 T 细胞识别与 IAg7 结合的胰岛素,结合方式出乎意料且亲和力较弱。
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10978-83. doi: 10.1073/pnas.1006545107. Epub 2010 Jun 1.
9
Molecular targeting of islet autoantigens.胰岛自身抗原的分子靶向。
Immunity. 2010 Apr 23;32(4):446-56. doi: 10.1016/j.immuni.2010.04.008.
10
Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes.自身免疫性糖尿病中,胰岛内产生的胰岛素肽可被独特的自身反应性 T 细胞识别。
Nat Immunol. 2010 Apr;11(4):350-4. doi: 10.1038/ni.1850. Epub 2010 Feb 28.